Diagnostic Robotics Raises $45 Million To Advance Medical Grade AI Triage

This week Diagnostic Robotics announced that they have raised $45 million in Series B financing. This round was led by StageOne investors with participation from Mayo Clinic, Technion - Israel Institute of Technology, and Bradley Bloom, co-founder of Berkshire Partners. The company will also become a Mayo Clinic Platform portfolio company. This round brings the company's total financing to $85 million. Diagnostic Robotics uses AI based predictive models to help patients manage chronic conditions and reduce emergency room visits.